Inmed Pharmaceuticals logo

Inmed Pharmaceuticals share price today

(INM)

Inmed Pharmaceuticals share price is $4.97 & ₹426.48 as on 7 Jan 2025, 2.30 'hrs' IST

$4.97

Market is closed - opens 8 PM, 07 Jan 2025

View live Inmed Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Inmed Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Inmed Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Inmed Pharmaceuticals share price movements

  • Today's Low: $4.95
    Today's High: $5.41

    Day's Volatility :8.41%

  • 52 Weeks Low: $2.41
    52 Weeks High: $15.70

    52 Weeks Volatility :84.62%

Inmed Pharmaceuticals Returns

PeriodInmed Pharmaceuticals IncIndex (Russel 2000)
3 Months
19.18%
0.0%
6 Months
1.43%
0.0%
1 Year
-37.2%
0.0%
3 Years
-99.19%
-19.8%

Inmed Pharmaceuticals Key Statistics

in dollars & INR

Previous Close
$4.97
Open
$5.0
Today's High
$5.41
Today's Low
$4.9549
Market Capitalization
$3.4M
Today's Volume
$15.5K
52 Week High
$15.696
52 Week Low
$2.414
Revenue TTM
$4.6M
EBITDA
$-7.9M
Earnings Per Share (EPS)
$230.4
PE Ratio
0.02
Profit Margin
-166.94%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-72.09%

How to invest in Inmed Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Inmed Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Inmed Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Inmed Pharmaceuticals or INM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Inmed Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Inmed Pharmaceuticals shares which would translate to 0.173 fractional shares of Inmed Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Inmed Pharmaceuticals, in just a few clicks!

Returns in Inmed Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Inmed Pharmaceuticals investment value today

Current value as on today

₹66,054

Returns

₹33,946

(-33.95%)

Returns from Inmed Pharmaceuticals Stock

₹37,168 (-37.17%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Inmed Pharmaceuticals

-54%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Inmed Pharmaceuticals on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -54% less investors are searching Inmed Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Inmed Pharmaceuticals

  • AdvisorShares Investments, LLC

    5.11%

  • Virtu Financial LLC

    0.60%

  • Renaissance Technologies Corp

    0.35%

  • HRT FINANCIAL LLC

    0.27%

  • Baader Bank INC

    0.16%

  • Citadel Advisors Llc

    0.08%

Analyst Recommendation on Inmed Pharmaceuticals

Sell

    0%Buy

    37%Hold

    62%Sell

Based on 8 Wall street analysts offering stock ratings for Inmed Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
0
0
0
Hold
3
3
3
Sell
5
5
5

Analyst Forecast on Inmed Pharmaceuticals

What analysts predicted

Upside of 302.41%

Current:

$4.97

Target:

$20.00

Insights on Inmed Pharmaceuticals

  • Price Movement

    In the last 1 month, INM stock has moved up by 9.6%
  • Price Movement

    In the last 3 years, INM stock has moved down by -99.2%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 1.28M → 1.26M (in $), with an average decrease of 1.4% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, -1.47M → -1.67B (in $), with an average decrease of 28840.3% per quarter
  • INM vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 56.5%
  • INM vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 154.4%
  • Price to Sales

    ForINM every $1 of sales, investors are willing to pay $8.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Inmed Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Inmed Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Inmed Pharmaceuticals Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Inmed Pharmaceuticals Inc
-2.07%
1.43%
-37.2%
-99.19%
-99.69%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Inmed Pharmaceuticals Inc
0.02
0.02
NA
0.0
-0.72
-0.39
NA
1.03
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Inmed Pharmaceuticals Inc
Sell
$3.4M
-99.69%
0.02
-166.94%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Inmed Pharmaceuticals

inmed is a clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. inmed's proprietary platform technology, product pipeline and accelerated development pathway are the fundamental value drivers of the company.
Organization
Inmed Pharmaceuticals
Employees
13
CEO
Mr. Eric A. Adams B.S. Chem., M.I.B.
Industry
Health Technology

Management People of Inmed Pharmaceuticals

NameTitle
Mr. Eric A. Adams B.S. Chem., M.I.B.
President, CEO & Director
Ms. N. Netta Jagpal
CFO & Corporate Secretary
Mr. Michael Woudenberg P.Eng.
Chief Operating Officer
Ms. Alexandra Diane-Janet Mancini M.Sc.
Senior Vice President of Clinical & Regulatory Affairs
Dr. Eric Chih-Hsien Hsu Ph.D.
Senior Vice President of Preclinical Research & Development
Dr. Sazzad Hossain M.Sc., Ph.D.
Co-Founder
Ms. Sarah Li CPA, CGA
VP of Accounting & Controller
Colin Clancy
Senior Director of Investor Relations
Mr. Jerry P. Griffin
Vice President of Sales & Marketing
Dr. Shane A. Johnson Ph.D.
Senior VP & GM of BayMedica

Important FAQs about investing in Inmed Pharmaceuticals from India :

What is Inmed Pharmaceuticals share price today?

Inmed Pharmaceuticals share price today stands at $4.97, Open: $5.00 ; Previous Close: $4.97 ; High: $5.41 ; Low: $4.95 ; 52 Week High: $15.70 ; 52 Week Low: $2.41. The stock opens at $5.00, after a previous close of $4.97. The stock reached a daily high of $5.41 and a low of $4.95, with a 52-week high of $15.70 and a 52-week low of $2.41.

Can Indians buy Inmed Pharmaceuticals shares?

Yes, Indians can invest in the Inmed Pharmaceuticals (INM) from India.

With INDmoney, you can buy Inmed Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Inmed Pharmaceuticals at zero transaction cost.

How can I buy Inmed Pharmaceuticals shares from India?

It is very easy to buy Inmed Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Inmed Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Inmed Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Inmed Pharmaceuticals stocks?

To start investing in Inmed Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Inmed Pharmaceuticals

Today’s highest price of Inmed Pharmaceuticals (INM) is $5.41.

Today’s lowest price of Inmed Pharmaceuticals (INM) is $4.95.

What is today's market capitalisation of Inmed Pharmaceuticals

Today's market capitalisation of Inmed Pharmaceuticals INM is 3.4M

What is the 52 Week High and Low Range of Inmed Pharmaceuticals

  • 52 Week High

    $15.70

  • 52 Week Low

    $2.41

What are the historical returns of Inmed Pharmaceuticals?

  • 1 Month Returns

    -2.07%

  • 3 Months Returns

    1.43%

  • 1 Year Returns

    -37.2%

  • 5 Years Returns

    -99.69%

Who is the Chief Executive Officer (CEO) of Inmed Pharmaceuticals

Mr. Eric A. Adams B.S. Chem., M.I.B. is the current Chief Executive Officer (CEO) of Inmed Pharmaceuticals.